Ear Disorders in Diseases of the Urogenital Apparatus [PDF]
John Sendziak
openalex +1 more source
Elexacaftor–Tezacaftor–Ivacaftor Improves Sinonasal Outcomes in Young Children With Cystic Fibrosis
ABSTRACT Background Severe chronic rhinosinusitis (CRS) is a near universal manifestation of cystic fibrosis. Elexacaftor/tezacaftor/ivacaftor (ETI) is an oral, small molecule, highly effective Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) corrector–potentiator drug.
Amanda L. Stapleton+10 more
wiley +1 more source
THE CONTROL AND PREVENTION OF EAR DISEASES AMONG SCHOOL CHILDREN. [PDF]
LOUIS J. LAUTENBACH
openalex +1 more source
ABSTRACT Background Elexacaftor/tezacaftor/ivacaftor (ETI) is a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) therapy that improves pulmonary function and chronic rhinosinusitis (CRS) in cystic fibrosis (CF) adults with at least one copy of the F508del CFTR mutation.
Margaux Petitjean+16 more
wiley +1 more source
Symposium of papers read at a scientific meeting of the surgical staff of Dr. Wendell C. Phillips' Clinic, Manhattan Eye, Ear and Throat Hospital, New York, April, 1906: Ocular manifestations in Intra‐cranial diseases of otitic origin [PDF]
W. E. Spicer
openalex +1 more source
MiR‐221‐3p Attenuates IL‐33‐Induced Mast Cell Cytokine Expression by Targeting KIT
ABSTRACT Background Mast cells (MCs) are involved in type 2 inflammation in chronic rhinosinusitis with nasal polyps (CRSwNP), which depends on interleukin (IL)‐33 stimulation. MiR‐221 is reported to be an important regulator of MCs, and miR‐221‐3p can be expressed in CRSwNP. However, the role of miR‐221‐3p in CRSwNP is unclear. Methods Ethmoid tissues
Ruowu Liu+11 more
wiley +1 more source
Josef Gruber (Professor of Otology in the Imperial Royal University of Vienna)— A Text-Book of the Diseases of the Ear. Translated from the Second German Edition, by special permission of the author, and edited by Edward Law M.D., M.R.C.S., and Jewell Coleman M.B., M.R.C.S., with 150 illustrations, and 70 coloured figures on two lithographic plates, London: H. K. Lewis. [PDF]
Dundas Grant
openalex +1 more source
ABSTRACT Background Chronic rhinosinusitis with nasal polyps (CRSwNP) significantly impacts patients’ quality of life (QoL). Standard treatments include nasal irrigations, nasal steroids, systemic corticosteroids, and functional endoscopic sinus surgery (FESS).
Anne‐Sophie Homøe+7 more
wiley +1 more source